The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...
This research comes at a time when an increasing number of Americans are reporting symptoms of depression. A 2023 Gallup survey found that self-reported rates of depression had increased by 10% ...